ProxyMiner / Diff
THERMO FISHER SCIENTIFIC INC. TMO
Comparing the 2025 proxy against the 2026 proxy.
Compare
CEO total Δ
+162.5% year-over-year
Peer churn
Members added or dropped across all peer groups
Policy + metric churn
Disclosures whose value moved or appeared/disappeared
Peer groups
Peer disclosure
2025 Tsr Peer Group
tsr · 29 → 28 members
23 kept · +5 · −6
Added
ELI LILLY & Co (LLY) · Medtronic plc (MDT) · TEXAS INSTRUMENTS INC (TXN) · PROCTER & GAMBLE Co (PG) · AUTOMATIC DATA PROCESSING INC (ADP)
Removed
AUTOMATIC DATA PROCESSING INC (ADP) · TEXAS INSTRUMENTS INC (TXN) · PNC FINANCIAL SERVICES GROUP, INC. (PNC) · Medtronic plc (MDT) · PROCTER & GAMBLE Co (PG) · THERMO FISHER SCIENTIFIC INC. (TMO)
2022 Tsr Peer Group
tsr · 29 → 0 members
0 kept · +0 · −29
Removed
3M CO (MMM) · Cigna Group (CI) · Medtronic plc (MDT) · ABBOTT LABORATORIES (ABT) · CISCO SYSTEMS, INC. (CSCO) · Merck & Co., Inc. (MRK) · AbbVie Inc. (ABBV) · CSX CORP (CSX) · Kongsberg Gruppen ASA/ADR (KBGGY) · AMGEN INC (AMGN) · DANAHER CORP /DE/ (DHR) · NIKE, Inc. (NKE) · ASTRAZENECA PLC (AZN) · Eaton Corp plc (ETN) · PFIZER INC (PFE) · AUTOMATIC DATA PROCESSING INC (ADP) · STRYKER CORP (SYK) · BECTON DICKINSON & CO (BDX) · GILEAD SCIENCES, INC. (GILD) · TEXAS INSTRUMENTS INC (TXN) · BIOGEN INC. (BIIB) · HONEYWELL INTERNATIONAL INC (HON) · BOEING CO (BA) · BOSTON SCIENTIFIC CORP (BSX) · ILLINOIS TOOL WORKS INC (ITW) · PNC FINANCIAL SERVICES GROUP, INC. (PNC) · BRISTOL MYERS SQUIBB CO (BMY) · JOHNSON & JOHNSON (JNJ) · THERMO FISHER SCIENTIFIC INC. (TMO)
2023 Peer Group
— · 20 → 0 members
0 kept · +0 · −20
Removed
3M CO (MMM) · CISCO SYSTEMS, INC. (CSCO) · Merck & Co., Inc. (MRK) · ABBOTT LABORATORIES (ABT) · DANAHER CORP /DE/ (DHR) · NIKE, Inc. (NKE) · AbbVie Inc. (ABBV) · ELI LILLY & Co (LLY) · PEPSICO INC (PEP) · AMGEN INC (AMGN) · GILEAD SCIENCES, INC. (GILD) · PFIZER INC (PFE) · BECTON DICKINSON & CO (BDX) · HONEYWELL INTERNATIONAL INC (HON) · PROCTER & GAMBLE Co (PG) · BRISTOL MYERS SQUIBB CO (BMY) · JOHNSON & JOHNSON (JNJ) · TEXAS INSTRUMENTS INC (TXN) · Broadcom Inc. (AVGO) · Medtronic plc (MDT)
Executive pay
Named executive compensation
| Executive | Status | From | To | Δ Total | Δ % | Δ At-risk |
|---|---|---|---|---|---|---|
Marc N. CasperChairman, President and Chief Executive Officer | ChangedCEO | $30,449,599 2024 | $79,923,350 2025 | +$49,473,751 | +162.5% | +4.4 pp |
Stephen WilliamsonSenior Vice President and Chief Financial Officer | Changed | $11,087,581 2024 | $6,781,012 2025 | -$4,306,569 | -38.8% | -8.5 pp |
Michel LagardeExecutive Vice President and Chief Operating Officer | Changed | $12,778,317 2024 | $8,907,174 2025 | -$3,871,143 | -30.3% | -5.5 pp |
Gianluca PettitiExecutive Vice President | Changed | $11,340,424 2024 | $8,080,467 2025 | -$3,259,957 | -28.7% | -5.8 pp |
Frederick LoweryExecutive Vice President | Changed | $8,529,377 2024 | $6,575,821 2025 | -$1,953,556 | -22.9% | -5.0 pp |
Governance
Policy guardrails
change in control
UnchangedNot extracted → Not extracted
“‘Double trigger’ change in control agreements”
clawback
Unchangedpresent → present
“Clawback policy”
compensation committee
UnchangedCompensation Committee → Compensation Committee
“Annual compensation setting process The Compensation Committee undertakes a number of activities each year”
compensation consultant
Unchangedindependent → independent
“Independent compensation consultant”
hedging
UnchangedNot extracted → Not extracted
“Insider trading policy; anti-hedging and anti-pledging policies”
pledging
UnchangedNot extracted → Not extracted
“Insider trading policy; anti-hedging and anti-pledging policies”
stock ownership guidelines
Unchangedpresent → present
“Stock ownership guidelines”
Performance markers
Metric facts
ceo pay ratio
Changed403 to 1 → 120 to 1
Numeric delta: -283.00
“in the case of employees who joined the company during 2025). The annual total compensation of our median employee (other than the CEO) for 2025 was $71,333. As disclosed in the Summary Compensation Table appearing on pa…”
median employee compensation
Changed$75,643 → $71,333
Numeric delta: -4310.00
“We determined the median employee from the remaining 118,745 persons (excluding our CEO) based on the sum of the annual salary and the target cash incentive for each employee as of October 3, 2025 (annualized in the case…”
revenue
Changed$42.9 billion → $10 billion
Numeric delta: -32900000000.00
“least May 2030, and to drive substantial long-term shareholder value through sustained TSR outperformance. Under Mr. Casper’s leadership as CEO, Thermo Fisher has transformed into a global leader serving the life science…”
operating income
UnchangedNot extracted → Not extracted
“students through STEM initiatives and contributing 100K+ colleague volunteer hours globally • Strong improvement in cybersecurity awareness and behavior and launched global digital acumen business resource group with 14 …”
Narrative
CD&A prose similarity
Coarse measure of how much the compensation discussion text moved year-over-year. Not a substitute for reading the actual filings.
17% shingled-prose overlap between the two filings.
2025: 72,715 chars · 2026: 48,531 chars
- Committee Report:52% overlap (519 → 538 chars)
- Pay Ratio (Item 402(u)):22% overlap (1,064 → 1,581 chars)
- Say-on-Pay proposal:0% overlap (854 → 1,624 chars)
Narrative
What actually changed in the CD&A
Sentence-level diff between the two filings. New disclosures appear first, then sentences whose wording shifted, then sentences the prior year had that are no longer present.
- changedThis compensation discussion and analysis provides an overview of the components of our 2025 executive compensation program and the 2024decisions of the Compensation Committee (referred to in this “Compensation discussion and analysis” section as the “Compensation Committee” or “Committee”) for our 2025 2024NEOs, who are:
- newNamed Executive Officer 2025 Title Marc N.
- newCasper* Chairman, President and Chief Executive Officer Stephen Williamson** Senior Vice President and Chief Financial Officer Michel Lagarde*** Executive Vice President and Chief Operating Officer Gianluca Pettiti* Executive Vice President Frederick Lowery*** Executive Vice President
- new* As announced on January 12, 2026, effective March 1, 2026 Marc N.
- newCasper became Chairman and Chief Executive Officer, and Gianluca Pettiti was promoted to the role of President and Chief Operating Officer.
- new** As announced on July 23, 2025, Mr. Williamson retired effective March 31, 2026.
- newMr. James R.
- newMeyer succeeded Mr. Williamson as Senior Vice President and Chief Financial Officer as of March 1, 2026.
- new*** As announced on January 12, 2026, each of Mr. Lagarde and Mr. Lowery decided to leave Thermo Fisher to pursue other opportunities.
- newMr. Lagarde departed the Company as of March 31, 2026 and Mr. Lowery departed the Company as of February 28, 2026.
- newCompensation philosophy and objectives
- newThe core design principles of our executive compensation program include the following:
- newPerformance-based: A substantial portion of executive compensation is “at-risk” and contingent on the achievement of predetermined performance objectives, which is intended to reward superior performance while holding executives accountable for under-performance
- newShareholder-aligned: Incentive programs are structured to align executive rewards with the creation of shareholder value over both the short-term and long-term.
- newMarket-competitive: Compensation levels are competitive with those of companies with which we compete for executive talent, which is achieved by positioning target compensation within a competitive range around the market median, with adjustments based on individual performance, experience and enterprise impact.
- newBy adhering to these principles, we believe our executive compensation program effectively supports our strategic and financial objectives, promotes sustained performance, and drives long-term value creation for shareholders, while enabling us to attract and retain the leadership talent necessary to successfully manage and grow our business.
- newThey also serve as the foundation for the Committee’s ongoing evaluation and enhancement of the effectiveness of our executive compensation program.
- new36 Thermo Fisher Scientific 2026 Proxy Statement
- changedWhat we do What we don’t do Deliver a significant themajority of compensation in the form of at-risk, variable pay No excise tax gross ups No plans that encourage excessive risk No guaranteed pay increases No guaranteed bonuses or equity awards No dividends paid on equity awards prior to vesting No excessive perquisites No pension or supplemental executive retirement plans Align pay with performance and Company strategy Utilize performance metrics closely aligned with the Company’s strategic growth drivers Benchmark compensation levels against a peer group of appropriate companies in related industries, of a similar size and business complexity Reference a competitive range around the market median when reviewing compensation for our NEOs Cap maximum payouts for our performance-based incentive plans Maintain a clawback policy for the recoupment of compensation in certain situations Maintain robust stock ownership requirements Require two-year Twoyearholding requirementon 50% of net stock vesting under the CEO’s time-andperformance-based restricted stock units Engage an independent compensation consultant Maintain double-trigger change in control provisions Conduct regular shareholder engagement on compensation and other stewardship topics NotaxgrossupsNoplansthatencourageexcessiveriskNoguaranteedpayincreasesNoguaranteedbonusesorequityawardsNodividendspaidonequityawardspriortovestingNohedgingorpledgingofCompanycommonstockbydirectorsorexecutivesNoexcessiveperquisitesNopensionorsupplementalexecutiveretirementplans(“SERPs”)
- newIndependent compensation consultant
- changedIn 2025, 2024,the Committee in its sole discretion retained Pearl Meyer as its independent compensation consultant.
- new• assists with the review and continued development of the executive and director compensation programs of the Company and its peer group
- new• analyzes relative pay and performance alignment of our compensation programs
- changed• informs the Committee and management of reviewsemerging trends and best practices in executive compensation and director compensation
- newThermo Fisher Scientific 2026 Proxy Statement 37
- newThe Committee, composed entirely of independent directors, oversees the Board’s responsibilities related to executive compensation, including for the CEO.
- newIt is responsible for approving and evaluating all executive compensation plans, policies, and programs, setting and assessing performance goals, administering equity programs, and overseeing management succession plans.
- changedTypically, during the first quarter of each calendaryear, the Committee conducts its anannual compensation review.
- newAs part of this process, the Committee considers input from its independent consultant, Pearl Meyer, and recommendations from the CEO regarding compensation for the other executive officers, including base salary adjustments, annual incentive opportunities, and equity award size and mix.
- newIn determining pay levels, the Committee exercises judgment and considers peer group data, Company and business unit performance, individual performance, market trends, shareholder feedback, and input from the CEO and non-employee directors.
- newThe Committee then approves any changes to compensation elements and assesses total compensation holistically to ensure alignment with the Company’s philosophy and strategic objectives.
- new38 Thermo Fisher Scientific 2026 Proxy Statement
- newType Element Objectives Base salary • Provide market competitive, fixed compensation for day-to-day responsibilities, taking into account the individual’s level of responsibility, time in role, and the criticality of their position Annual incentive • Promote, incentivize and reward the achievement of key strategic and financial performance measures; promote retention • Drive achievement of key corporate performance goals Long-term incentives Performance-based restricted stock units • Designed to encourage executives to achieve strong goals in key performance metrics selected to drive long-term performance and shareholder value creation • Encourage equity ownership and executive retention, reinforce the need for long-term sustained financial performance and align the interests of management and shareholders For more information on our long-term incentive mix philosophy, see “2025 annual equity award mix” on page 43.
- changedStock options • Promote the long-term value-creating actions necessary to increase the market value of stock, as award only provides value if our stock price appreciates; promote long-term retention •Stock-basedincentivecompensationthatvestsin4equalannualinstallmentsTime-based restricted stock units • Promote long-term retention, stock ownership, and alignment of interests with shareholders •Stock-basedincentivecompensationthatvestsover3.5years
- new• Our compensation program is designed to effectively align with the Company’s operating plan and long-term business strategy, focused on driving a balanced mix of top-line and bottom-line financial results, along with a set of strategic initiatives designed to motivate management to achieve key business objectives that are critical for advancing our growth strategy.
- changed• We deliver a significant achievethisbydeliveringthemajority of compensation in the form of at-risk variable pay that is directly tied to clearly articulated strategic and financial performance measures.
- changed• To ensure alignment with shareholder value creation creation,we also assess TSR relative to the 2025 2024TSR Peer Group.
- newThermo Fisher Scientific 2026 Proxy Statement 39
- newPeer groups
- newThe Committee has historically used two peer groups: the compensation peer group and the total shareholder return peer group (“TSR Peer Group”):
- new• The compensation peer group is used to ensure alignment with our goal of providing market-competitive compensation programs.
- newThe compensation peer group is used to benchmark executive compensation practices and pay levels against size- appropriate and business relevant companies with which we compete for talent, both inside and outside of our industry.
- new• The TSR Peer Group is used to measure our relative performance, including for determining relative performance in our PRSU awards.
- newThe TSR Peer Group is made up of the companies in our the compensation peer group, supplemented by a set of historically high performing companies outside of our compensation peer group.
- newBeginning in 2026, the Committee revised the PRSU design so that relative TSR performance will be measured against the S&P 500 index.
- newDetermining our peer groups
- newEach year, the Committee, in consultation with its independent compensation consultant, reviews which peer companies it believes best serve as a reference point for the company based on several factors including industry, revenue, market capitalization, and operational complexity.
- newIn July 2024, the Committee conducted its annual review of the compensation peer group and the TSR Peer Group for the 2025 compensation program.
- changedInJuly2024,The Committee conducteditsannualreviewofthePeerGroupandremoved 3M Company from the compensation ourpeer group Group,due to a recentdivestiture which reduced its relevance to the Company from an industry and revenue perspective.
- newThe Committee determined the 2025 TSR Peer Group would remain unchanged from 2024 TSR Peer Group.
- changed2025 2024TSR PEER GROUP Compensation Peer Group 3MCompanyCiscoSystems,Inc.MerckKGaAAbbott Laboratories AbbVie CSXCorporationNIKE,Inc. Amgen AbbVieInc. Becton Dickinson and Company Bristol-Myers Squibb Broadcom DanaherCorporationPepsiCo,Inc. Cisco Systems, AmgenInc. Danaher Corp Eli Lilly Lilyand Company Pfizer,Inc.AstraZenecaplcGilead Sciences Inc.StrykerCorporationAutomaticDataProcessing,Inc. Honeywell International Inc. Johnson & Johnson Medtronic, plc Merck & Co, Inc. NIKE, Inc. PepsiCo, Inc. Pfizer, Inc. Texas Instruments Inc. The Procter & Gamble Co. 3M IncorporatedBecton,DickinsonandCompany AstraZeneca plc Automatic DataProcessing, Inc. Boston Scientific Corp. CSX Corporation IQVIA Holdings Inc. Merck KGaA Stryker Corporation The Boeing Company BostonScientificCorp.Johnson&JohnsonThe PNC FinancialServices FinancialServicesGroup, Inc.Bristol-MyersSquibbCompanyMedtronic,Inc.TheProcter&GambleCompanyBroadcomInc.Merck&Co.,Inc.ThermoFisherScientificInc.
- changedOur positioning relative to the compensation peer group Group.
- changedAt the time of the Committee’s thisreview in July 2024, the compensation 2025peer group companies ranged from 0.4x to 2.16x of Thermo Fisher’s revenue and 0.32x to 3.89x of our market capitalization.
- newThe Committee considers peer data to be a helpful reference to assess the competitiveness and appropriateness of our executive compensation program.
- newWhile the Committee seeks to ensure target compensation opportunities are established within a competitive range around the peer group median when setting target compensation levels, it applies business judgment and experience to determine individual compensation.
- changedThe individual positioning of pay will stillvary as the Committee takes into account a range of factors (e.g. tenure, experience, performance, scope of role) when determining pay levels.
- new40 Thermo Fisher Scientific 2026 Proxy Statement
- newThermo Fisher Scientific 2026 Proxy Statement 41
- changed2025 2024Compensation decisions and outcomes
- newThe Committee believes that it is important that each NEO receives a market-competitive base salary, taking into account tenure, experience, performance and expected contributions.
- newNamed Executive Officer 2024 Base Salary(1) 2025 Base Salary(2) Increase Marc N.
- newCasper $ 1,740,000 $ 1,800,000 3.4% Stephen Williamson $ 1,055,132 $ 1,107,889 5.0% Michel Lagarde $ 1,140,468 $ 1,174,682 3.0% Gianluca Pettiti $ 975,000 $ 1,050,000 7.7% Frederick Lowery $ 900,000 $ 940,000 4.4% (1) As in effect on December 31, 2024.
- changed(2) (1)As in effect on December 31, 2025. 2023.
- newOur Annual Incentive Plan (AIP) incentivizes the Company’s performance against the annual operating plan, focused on organic revenue growth, adjusted net income and free cash flow (which together account for 70% of the award).
- newIn addition, the Committee uses a scorecard designed to hold executives accountable for efforts towards advancing key strategic initiatives, designed to drive meaningful growth over the long-term and effective execution of our capital deployment strategy (accounting for 30% of the award).
- newThe Committee believes this combination of financial, operating and strategic metrics reflects the appropriate balance of driving both top- and bottom-line growth and motivating management to achieve key business objectives that are critical for advancing our growth strategy, as reflected below:
- changed35% MeasureWhyItMattersFinancialOrganic revenue growth* • Strong indicator of our long-term ability to drive shareholder value • Allows comparison of financial results to both acquisitive and non-acquisitive peer companies • Prevalent, industry-relevant measure of growth 30% Adjusted net income* • Reflects achievement of our strategic goals by encouraging efficient operations and resource allocations, in order to maximize earnings relative to the revenue environment • Ensures all employees can contribute to the success of the Company 5% Free cash flow* • Reflects quality of earnings and cash flows that may be reinvested in our businesses, used to make acquisitions, or returned to shareholders in the form of dividends and/or share repurchases 30% Non-FinancialAdvancingourStrategic goals position• Incentivizes executives to support our commitment to matters of strategic importance to support •Supportsthe Company’s sustainable, long-term performance PositionCompanytodrivemeaningfulgrowthinrevenueandadjustedoperatingincomethroughthestrategicplanhorizon• Strong indicator of our long-term ability to driveshareholdervaluebyeffectively meet meetingthe needs of our customers in all of the end markets that we serve Effectivelyexecutecapitaldeploymentstrategy• Aligns organizational focus and reinforces Properlymanagingthe importance of making progress on strategic initiatives that drive useofcapitalthroughacquisitions,dividends,sharerepurchasesanddebtrepaymentisofparamountimportancetotheCompany’slong-term value creation financialhealth
- newIn February of each year, the Committee sets annual performance goals based on the Company’s annual operating plan and 5-year strategic plan, which serve as the basis for the earnings guidance communicated to investors.
- changedThe annual operating plan builds on prior-year theprioryear’sresults and reflects isbasedonthe anticipated business environment.
- newThe Committee also considers external factors, including the Company and industry outlooks, historical and projected industry growth rates, and analyst performance expectations.
- changedAs a result, the Company’s goalsestablishedforourannual companyperformance measures are closely aligned with our annual corporateoperating plan, long-term strategy planand the financial objectives we communicate to investors.
- newEstablishing target levels.
- newThe Committee sets performance targets for each metric so that the target payout (100% of target bonus) reflects attractive financial performance achievable with strong execution.
- newAchieving payouts above target requires outstanding performance.
- newIn February 2025, the Committee established performance goals based on the Company’s operating plan and strategic outlook at that time.
- newAs the year progressed however, the Company operated in an environment characterized by significant uncertainty and an accelerated pace of change.
- newFollowing the first quarter, we updated our external guidance to reflect the anticipated impact of macroeconomic factors and the Company’s mitigating actions.
- newIn that context, the Committee carefully evaluated whether corresponding adjustments to the compensation metrics would be appropriate.
- newAfter thoughtful consideration, the Committee concluded that maintaining our established performance standards, and holding management to a heightened level of accountability, was in the best interests of shareholders.
- newSummary and discussion of 2025 AIP achievement
Removed from 2025
- Named Executive Officer Title Date of Appointment to Current Role Tenure at Company (in Years) Marc N.
- Casper Chairman, President and Chief Executive Officer October 2009 23 Stephen Williamson Senior Vice President and Chief Financial Officer August 2015 23 Michel Lagarde Executive Vice President and Chief Operating Officer January 2022 9 Gianluca Pettiti Executive Vice President December 2021 19 Frederick Lowery Executive Vice President April 2024 19
- 2025 Proxy Statement | thermofisher.com 29
- 2024 vote on Named Executive Officer compensation and shareholder engagement
- At the 2024 Annual Meeting of Shareholders, our shareholders approved say-on-pay with an 89% favorable advisory vote.
- Throughout 2024, we continued our robust shareholder engagement program to better understand shareholder views on our governance and compensation practices.
- During 2024, following the 2024 Annual Meeting of Shareholders, we proactively contacted shareholders representing approximately 46% of our outstanding shares to solicit their feedback and ensure that we had firsthand knowledge of their perspectives and any concerns specifically related to our executive compensation programs.
- Our engagement, comprised of members of the Compensation Committee and members of the management team representing legal, investor relations, and sustainability teams, met with 17 shareholders representing over 27% of our outstanding shares, including additional shareholders that requested meetings with our team.
- These meetings allow us to better understand our shareholders’ perspectives and develop appropriate responsive actions.
- In our engagement meetings, our shareholders expressed general satisfaction with our executive compensation program.
- They also expressed a range of alternatives on how to structure the program.
- Topic What we heard How we responded Disclosure • Positive feedback on the “Executive summary” section and enhanced narrative regarding our long-term incentive mix strategy • The “Compensation discussion and analysis” includes an “Executive summary” section explaining in greater detail the Compensation Committee’s executive compensation program design choices and program results.
- See page 31 • The “Compensation discussion and analysis” includes a “2024 annual equity award mix” section explaining in greater detail the Compensation Committee’s long-term incentive mix philosophy.
- See page 40 Long-term incentive (“LTI”) mix • Shareholders expressed a range of views on the mix of long-term incentives in our executive compensation program; some expressed a preference for a greater mix of performance-based restricted stock units, and others expressed a preference for more use of stock options • Preference for encouraging longer-term equity holding • In February 2024, in response to shareholder feedback, the Committee changed the mix of the annual equity grant of our CEO, to (i) increase the percentage of performance-based restricted stock unit awards to 50% (previously 40%), and (ii) increase the percentage of stock options to 50% (previously 40%).
- For 2024, Mr. Casper did not receive time-based restricted stock units (previously 20%), and the Committee considers his grant to be 100% performance-based, as he will only receive value under his awards if the Company meets its key operational goals and the Company’s stock price appreciates from the time of grant.
- See page 40 • In February 2025, in response to shareholder feedback regarding long-term holding of equity awards, the Compensation Committee increased the terms of our stock option awards from 8 years to 10.
- See page 40 Peer Group • Shareholders asked about industry dynamics impacting the composition of the compensation benchmarking Peer Group and the TSR peer group used for our performance-based equity awards • The Compensation Committee conducts a comprehensive review of the Peer Group annually, and considers a number of factors, including industry, revenue and market capitalization.
- • During the July 2024 review, the Committee determined to remove 3M Company from our Peer Group, due to a recent divestiture which reduced its relevance to the Company from an industry and revenue perspective.
- The Company now falls at the 50th percentile of the 2025 Peer Group in terms of revenue and 65th percentile in terms of market capitalization.
- See page 48 • For the 2024 compensation cycle the Compensation Committee updated the TSR peer group used for the our performance-based equity awards (the “2024 TSR Peer Group”).
- Updates to the 2024 TSR Peer Group are generally aligned with changes to the Peer Group based on relevance from a revenue, market capitalization, and operational complexity standpoint.
- See page 43
- Looking to the future, the Company is committed to maintaining ongoing communication with our shareholders, to ensure we continue to remain fully aware of shareholder expectations for our executive compensation practices.
- 30 2025 Proxy Statement | thermofisher.com
- Executive summary
- We delivered a strong year in 2024.
- Our team executed very well to enable the success of our customers and deliver differentiated financial performance.
- Our revenue was $42.9 billion, GAAP diluted earnings per share attributable to Thermo Fisher (“EPS”) was $16.53, adjusted EPS* was $21.86 per share, and we generated strong free cash flow* of $7.32 billion.
- We once again strengthened our long-term competitive position through the execution of our proven growth strategy, delivering another year of high-impact innovation, and advancing our trusted partner status with customers.
- We delivered meaningful share gain with our industry leading products, services, and expertise.
- During the year we leveraged the power of our PPI Business System to deliver operational excellence and strong commercial execution, resulting in significant operational efficiencies and robust free cash flow.
- In 2024 we executed on our capital deployment strategy, deploying over $7 billion in capital, including over $4 billion of capital returned through share repurchases and dividends, and advanced our leadership position in protein research through the $3.1 billion acquisition of Olink.
- Executive compensation program aligned with the shareholder experience
- We strive to align the interests of our executive team with the interests of our shareholders by tying their incentive compensation opportunities to the achievement of specific strategic and financial goals aligned with sustainable long-term shareholder value creation.
- Our executive compensation program is designed such that performance-based pay constitutes a significant majority of our executives’ total potential compensation.
- We aim to set rigorous financial and non-financial targets to reward the achievement of both short-term and long-term performance success, as well as to retain, develop and motivate our key talent.
- Our executive compensation is predominantly at-risk and performance-based.
- For our compensation program to be successful, it needs to effectively align with our key strategic and financial goals.
- For 2024, we delivered 92% of the target compensation for our CEO and 87% of the target compensation for our other NEOs in the form of at-risk, variable pay that is directly tied to clearly articulated strategic and financial performance metrics.
- The 2024 target direct compensation mix for our CEO and other NEOs is on page 33 under “Components of our annual compensation program.”
- In February 2024, in response to shareholder feedback, the Committee changed the mix of the annual equity grant of our CEO, to (i) increase the percentage of performance-based restricted stock unit awards to 50% (previously 40%), and (ii) increase the percentage of stock options to 50% (previously 40%).
- For 2024, Mr. Casper did not receive time-based restricted stock units (previously 20%), and the Committee considers his grant to be 100% performance-based, as he will only receive value under his awards if the Company meets its key operational goals and the Company’s stock price appreciates from the time of grant.
- Rigorous performance targets were set to incentivize strong performance and appropriately reflected the applicable macroeconomic environment and the continued roll-off of COVID-19 pandemic related revenue.
- The performance metrics used in our 2024 annual and long-term incentive programs reflect a focus on incentivizing the Company’s performance against the operating plan, including with respect to organic revenue growth, adjusted net income, free cash flow, adjusted earnings per share, and continued focus on relative total shareholder return.
- The Committee believes the use of these metrics in our compensation program design is appropriate and promotes consistency with metrics that many investors use to evaluate the Company’s financial performance.
- Consistent with prior years, our 2024 targets aligned with our publicly disclosed outlook for the year, including the expected negative impact in 2024 from the continued roll-off of COVID-19 pandemic related revenue, which was expected to decline year over year as the societal need for COVID-19 testing, vaccines and therapies continued to reduce.
- The Committee believes the performance targets it established for 2024 appropriately reflected the dynamic macroeconomic environment and were appropriately challenging.
- For each financial metric, the Committee set the performance target at a level it believed would represent attractive financial performance within our industry and would require strong execution, while requiring what it believed would be outstanding performance to achieve the maximum payout level.
- The Committee believes it is important to reward for above-industry performance to support the retention of key talent amidst multiple years of market uncertainty in a highly competitive environment, as our executives are critical to executing on our long-term strategic objectives.
- Talent retention awards for executives.
- In 2024, to incentivize above-market value creation and to retain key executives, in connection with their annual equity awards, each of our NEOs received a special TSR long-term incentive stock option award.
- The Committee made these awards to retain key talent amidst market uncertainty in a highly competitive environment for key talent, as our executives are critical to executing on our strategic objectives.
- The awards were designed to further align executive compensation with long-term shareholder value creation:
- • Ensure leadership continuity for the long-term.
- The Committee believes the awards will support our talent retention objectives by promoting stability, as the award cliff vests (subject to performance) at the end of the three-year period.
- The options carry an 8-year term to promote outstanding, long-term financial performance.
- • Further align executive compensation with long-term shareholder value creation.
- The Committee believes the awards will incentivize long-term shareholder value creation since the option award will be earned based on the Company’s relative TSR out-performance over a three-year period.
- In order for the award to pay out, the Company must outperform as compared to a high-performing peer group.
- Structuring the award in the form of options ensures executives will only receive value if the Company’s share price appreciates from the Company’s share price at the time of grant.
- This award therefore ensures alignment with shareholders as executives are motivated to take actions that are aligned with long-term value creation.
- Underscoring the rigor of this performance incentive opportunity, as of December 31, 2024, the TSR long-term incentive stock option awards were underwater and had zero intrinsic value.
- For more information on these awards, please see “TSR long-term incentive stock option awards” on page 45.
- Talent retention awards for non-executive key talent.
- Recognizing the importance of retaining key talent below the executive level, amidst such market uncertainty, the Committee also broadly took action to secure and incentivize the ongoing efforts of non-executive key talent, with the grant of special time-based restricted stock units that further enhance the retentive value of their equity stakes in the Company.
- * Adjusted EPS and free cash flow are financial measures that are not prepared in accordance with generally accepted accounting principles (“GAAP”).
- Appendix A to this Proxy Statement defines these and other non-GAAP financial measures and reconciles them to the most directly comparable historical GAAP financial measures.
- 2025 Proxy Statement | thermofisher.com 31
- Compensation objectives
- The goal of our executive compensation program is to provide market-competitive total compensation programs that promote the achievement of key strategic and financial performance, motivate long-term value creation, align executive officers’ interests with those of our shareholders, and attract and retain the best possible executive talent.
- Compensation philosophy
- We believe the most effective way to achieve these objectives is to reference the market median for target direct compensation, with adjustment for performance and experience, and to offer performance-based incentives tied to clearly articulated performance measures aligned to our key strategic and financial goals that reward our executives for over-performance and hold them accountable for under-performance.
- This philosophy is the foundation for evaluating and continuously improving the effectiveness of our executive pay program.
- The following are the core elements of our executive compensation philosophy:
- Performance-Based Shareholder Aligned Market Competitive A significant portion of executive compensation should be “at-risk,” performance-based pay Incentives should be structured to create a strong alignment between executives and shareholders on both a short-term and long-term basis Compensation levels and programs for executives should be competitive relative to the markets in which we operate and compete for talent
- By incorporating these core design elements, we believe our executive compensation program is in line with, and supportive of, our objectives of driving and rewarding performance and creating long-term value for our shareholders.
- In addition, we believe our executive compensation program is effective in attracting and retaining the level of talent we need to successfully manage and grow our business.
- 32 2025 Proxy Statement | thermofisher.com
- Type Element Link to Shareholder Value Key Features Base salary Provide market competitive, baseline compensation to attract and retain the best possible executive talent • Reviewed annually; changes generally effective March/April • Reference market median for all NEOs • Takes into account level of responsibility, time in role, and individual performance Annual incentive Promote, incentivize and reward the achievement of key strategic and financial performance measures; promote retention • Cash-based • Reference market median for all NEOs for target total cash (base salary plus target annual incentive) • Maximum opportunity capped at 200% of target • Based on performance goals tied 70% to financial measures (organic revenue growth, adjusted net income, free cash flow)*, and 30% to non-financial strategic measures Long-term incentives Performance-based restricted stock units Align interests of executives with those of our shareholders by motivating and rewarding achievement of financial performance and long-term shareholder value; promote retention • Reward achievement of financial goals (organic revenue growth, adjusted EPS)*, and align interests of executives with those of our shareholders by assessing TSR relative to the 2024 TSR Peer Group over the long-term • Stock-based incentive compensation that, if earned, vests in 3 annual installments, subject to a relative TSR metric based on stock price performance over a three-year performance period For more information on our long-term incentive mix philosophy, see “2024 annual equity award mix” on page 40.
- * Organic revenue growth, adjusted net income, free cash flow and adjusted EPS are financial measures that are not prepared in accordance with GAAP.
More changes truncated for legibility. Open the filings on SEC for full prose.
Cells reading “Not extracted” mean the deterministic extractor didn’t pick up that disclosure for the listed filing — not that it isn’t in the proxy. Open the company workspace and use Ask to query the CD&A directly.